594 related articles for article (PubMed ID: 17182988)
1. Multiple biomarkers for the prediction of first major cardiovascular events and death.
Wang TJ; Gona P; Larson MG; Tofler GH; Levy D; Newton-Cheh C; Jacques PF; Rifai N; Selhub J; Robins SJ; Benjamin EJ; D'Agostino RB; Vasan RS
N Engl J Med; 2006 Dec; 355(25):2631-9. PubMed ID: 17182988
[TBL] [Abstract][Full Text] [Related]
2. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS
N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742
[TBL] [Abstract][Full Text] [Related]
3. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.
Ingelsson E; Pencina MJ; Tofler GH; Benjamin EJ; Lanier KJ; Jacques PF; Fox CS; Meigs JB; Levy D; Larson MG; Selhub J; D'Agostino RB; Wang TJ; Vasan RS
Circulation; 2007 Aug; 116(9):984-92. PubMed ID: 17698726
[TBL] [Abstract][Full Text] [Related]
4. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
[TBL] [Abstract][Full Text] [Related]
5. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J
N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203
[TBL] [Abstract][Full Text] [Related]
6. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Blankenberg S; McQueen MJ; Smieja M; Pogue J; Balion C; Lonn E; Rupprecht HJ; Bickel C; Tiret L; Cambien F; Gerstein H; Münzel T; Yusuf S;
Circulation; 2006 Jul; 114(3):201-8. PubMed ID: 16831981
[TBL] [Abstract][Full Text] [Related]
7. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
[TBL] [Abstract][Full Text] [Related]
8. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
Ridker PM; Rifai N; Rose L; Buring JE; Cook NR
N Engl J Med; 2002 Nov; 347(20):1557-65. PubMed ID: 12432042
[TBL] [Abstract][Full Text] [Related]
9. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C and the risk of death and cardiovascular events among elderly persons.
Shlipak MG; Sarnak MJ; Katz R; Fried LF; Seliger SL; Newman AB; Siscovick DS; Stehman-Breen C
N Engl J Med; 2005 May; 352(20):2049-60. PubMed ID: 15901858
[TBL] [Abstract][Full Text] [Related]
13. Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function.
Kathiresan S; Gona P; Larson MG; Vita JA; Mitchell GF; Tofler GH; Levy D; Newton-Cheh C; Wang TJ; Benjamin EJ; Vasan RS
Circulation; 2006 Feb; 113(7):938-45. PubMed ID: 16476848
[TBL] [Abstract][Full Text] [Related]
14. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.
Zairis MN; Tsiaousis GZ; Georgilas AT; Makrygiannis SS; Adamopoulou EN; Handanis SM; Batika PC; Prekates AA; Velissaris D; Kouris NT; Mytas DZ; Babalis DK; Karidis KS; Foussas SG
Int J Cardiol; 2010 Jun; 141(3):284-90. PubMed ID: 19157603
[TBL] [Abstract][Full Text] [Related]
15. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
[TBL] [Abstract][Full Text] [Related]
17. Multiple biomarkers for mortality prediction in peripheral arterial disease.
Amrock SM; Weitzman M
Vasc Med; 2016 Apr; 21(2):105-12. PubMed ID: 26762418
[TBL] [Abstract][Full Text] [Related]
18. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
Güder G; Bauersachs J; Frantz S; Weismann D; Allolio B; Ertl G; Angermann CE; Störk S
Circulation; 2007 Apr; 115(13):1754-61. PubMed ID: 17372171
[TBL] [Abstract][Full Text] [Related]
19. Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.
Bodí V; Sanchis J; Llàcer A; Fácila L; Núñez J; Pellicer M; Bertomeu V; Ruiz V; Chorro FJ
Am Heart J; 2005 Feb; 149(2):268-74. PubMed ID: 15846264
[TBL] [Abstract][Full Text] [Related]
20. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
